Episode notes
This week, our conversations are with Wenyan Leong, director of APAC commercial and global strategic partnerships for cell and gene therapies at Terumo Blood and Cell Technologies, and Morten Graugaard, CEO of Orbis Medicines.
Interview times:
04:01 Terumo BCT
24:52 Orbis Medicines
Terumo Blood and Cell Technologies shows integrated 3-in-1 CAR-T workflow with quantum platform
Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, recently published a new protocol in a paper demonstrating expanded capabilities for its quantum system to unlock rapid CAR-T cell expansion.
The protocol consolidates the processes of T cell ac ...
Keywords
biotechbiotechnologyOrbis MedicinesmacrocyclesCAR-TTerumo BCT